Oseltamavir: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: Antiviral - neuraminidase inhibitor | ||
*Dosage Forms: | *Dosage Forms: capsule (30, 45, 75mg), powder for PO susp (6mg/mL) | ||
*Common Trade Names: | *Common Trade Names: Tamiflu | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 03:27, 1 November 2017
General
- Type: Antiviral - neuraminidase inhibitor
- Dosage Forms: capsule (30, 45, 75mg), powder for PO susp (6mg/mL)
- Common Trade Names: Tamiflu
Adult Dosing
Influenza
75mg PO BID x5d
Pediatric Dosing
5 day course
- 1-8 months: 3mg/kg PO BID
- 9-23 months: 3.5mg/kg PO BID
- 2-12 years:
- <15kg: 30mg PO BID
- 16-23kg: 45mg PO BID
- 24-40kg: 60mg PO BID
- >40kg: 75mg PO BID
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: